期刊文献+

Cyclin D1反义寡核苷酸对Tca8113/CDDP细胞基因转录表达的影响 被引量:4

The influence on expression of cyclin D1 by anti-sense oligonucleotide expression vector
下载PDF
导出
摘要 目的:构建细胞周期蛋白D1(cyclin D1)的反义寡核苷酸真核表达载体,并检测其转染Tca8113/CDDP细胞系后的表达情况。方法:以Tca8113/CDDP细胞总RNA为模板,应用RT-PCR法扩增cyclin D1全长,通过克隆至pUCm-T载体中,测序完全正确;经IPTG诱导,可正确表达蛋白。上下游分别利用H ind III和EcoRI的酶切位点插入真核表达载体pcDNA3.1,测序鉴定;并构建表达cyclin D1反义寡核苷酸的2个重组载体,通过Lipofectam ine将其导入Tca8113/CDDP细胞系中,G418筛选获得阳性稳定表达细胞系;通过RT-PCR、免疫组化检测cyclin D1基因转录和蛋白表达。结果:成功构建pcDNA3.1-cyclin D1真核表达载体,分别命名为pcDNA3.1空载体(Co)、cyclin D1m RNA5’端为靶区的反义载体(C5’)、cyclin D1m RNA3’端为靶区的反义载体(C3’)、cyclin D1正义载体(CD1)。3’端反义寡核苷酸转染细胞后,cyclin D1m RNA表达水平降低58.8%,m RNA5’端反义寡核苷酸组无明显抑制。免疫组化结果显示,转导正义寡核苷酸组cyclin D1阳性表达为最高,转导m RNA3’端、m RNA5’端反义寡核苷酸组为弱阳性表达。结论:cyclin D1m RNA3’端反义寡核苷酸能明显抑制cyclin D1在Tca8113/CDDP中的表达,为进一步研究逆转Tca8113/CDDP耐药性提供了实验工具。 PURPOSE: To construct eurokaratic expression vectors of pcDNA3.1-cyclin D1 and pcDNA 3.1-Anti-cyclin D1, and evaluate their influence on the expression of cyclin D1 in stable transfected Tca8113/CDDP cells. METHODS: The full length of cyclin D1 and its antisense fragments were acquired from Tca8113/CDDP cells by RT-PCR. These cDNA fragments were inserted into pUCm-T vector and the full length sequenced. Induced by IPTG, the vector could express cyclin D1 protein in vitro. After double digested by Hind III and EcoRI at the two ends of these cDNA fragments, these cDNA fragments were inserted into pcDNA3.1 vector and transfected into Tca8113/CDDP cells with the help of Lipfectamin 2000. Stable cell lines were acquired after continually selected with G418 for 4 weeks. The expression of cyclin D1 was detected with RT-PCR and immunohistochemical staining. RESULTS: pcDNA3.1-cyclin D1, pcDNA3.1-Anti-5' and pcDNA3.1-Anti-3' vectors were constructed and named as pcDNA3.1(CO), pcDNA3.1-Anti-cyclin D1 5'(C5'), pcDNA3.1-Anti-cyclin D1 3'(C3') and pcDNA3.1-cyclin D1(CD1), respectively. The expression of cyclin D1 in Tca8113/CDDP cells transfected with C3' was significantly inhibited and the inhibition rate was 58.8%. While C5' could not inhibit the expression of cyclin D1. The protein level of cyclin D1 was strongly positive in Tca8113/CDDP-C0, Tca8113/CDDP-CD1 and Tca8113/CDDP-C5' cells. It was obviously repressed in Tca8113/CDDP-3' cells. CONCLUSION: We successfully constructed pDNA3.1-cyclin D1 vector and pcDNA3.1-Anti-cyclin D1 vectors. Detected with RT-PCR and immunohistochemical staining, the mRNA level and protein expression of cyclin D1 were significantly inhibited in C3' transfected Tca8113/CDDP cells,which may provide a good experimental tool for further studying in reversing the multidrug resistance of Tca8113/CDDP cells.
出处 《上海口腔医学》 CAS CSCD 2005年第2期169-172,共4页 Shanghai Journal of Stomatology
关键词 反义寡核苷酸 真核表达载体 细胞周期蛋白D1 细胞系 Antisense oligonucleotide Eurokaratic expression vector Cyclin D1 Cell line
  • 相关文献

参考文献6

  • 1周晓健,李卿,陈万涛.人舌鳞状细胞癌顺铂耐药细胞系的建立及其耐药基因表达[J].上海口腔医学,2003,12(6):432-435. 被引量:4
  • 2Ho A, Dowdy SF. Regulation of G(1) cell-cycle progression by oncogenes and tumor suppressor genes[J]. Curr Opin Genet Dev,2002,12(1):47-52.
  • 3Olie RA, Simoes-Wust AP, Baumann B, et al. A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy[J]. Cancer Res,2000,60(11):2805-2809.
  • 4Sczakiel G. The design of antisense RNA[J]. Antisense Nucleic Acid Drug Dev, 1997,7:439-444.
  • 5Wagner RW, Nishikura K. Cell cycle expression of RNA duplex unwinding activity in cells[J]. Mol Cell Biol, 1988,8(2):770-777.
  • 6Antony T, Thomas T, Shirahata A, et al. Selectivity of polyamines on the stability of RNA-DNA hybrids containing phosphodiester and phosphorothicate oligodeoxyribonucleotides[J]. Biochemistry,1999,38(33):10775-10784.

二级参考文献9

  • 1Gottesman MM.How cancer cells evade chemotherapy:16th Richard and Hnda Foundation Award Lecture [J]. Cancer Res, 1993,53:747-754.
  • 2Misawa T, Kikawa F, Maeda O, et al. Establishment and characterization of acquired resistance to platinum anticancer drugs in human ovarian carcinoma cells [J]. Jpn J Cancer Res,1995,86:88-94.
  • 3Den Boer ML, Pieters R,Kazemier KM, et al. Relationship between major vault protein/lung resistance protein, multidmg resistance associated protein P-glycoprotein, and drug resistance in child leukemia[J]. Blood, 1998,91:2092-2098.
  • 4List A, Spier C, Grogan T, et al. Overexpression of the major vault transporter lung resistance protein predicts treatment outcome in acute myeloid leukemia[J]. Blood, 1996,87:2464-2469.
  • 5Izquierdo M, Van der Zee A, Vermoken J. Drug resistance associated marker LRP for prediction of response to chemotherapy and prognosis in advanced ovarian carcinoma [J]. J Natl Cancer Inst, 1995,87: 1230-1237.
  • 6Tanner B, Hengstler G, Diertrich B, et al. Glutathione, GST-π,GSt-c in relationship to drug resistance in ovarian cancer [J].Gynecol Oncol, 1997,65:54-62.
  • 7Beketic Oreskovic L, Duran GE,Chen G, et al. Decreased mutation rate for cellular resistance to doxorubicin and suppression of mdrl gene activation by the cyclosporin psc 833[J]. J Natl Cancer Inst,1995,87:1593-1602.
  • 8江宏兵,廖小宜,李芃.顺铂诱导颊癌细胞凋亡及凋亡分子(Apo-1)表达的实验研究[J].华西口腔医学杂志,1999,17(4):300-303. 被引量:3
  • 9周晓健,陈万涛,何荣根,林李嵩.顺铂诱导Tca8113细胞凋亡及周期特异性[J].上海口腔医学,2000,9(3):161-163. 被引量:4

共引文献3

同被引文献41

  • 1张萍,陈万涛,周晓建,邱蔚六.细胞周期因子CyclinDs的表达水平与口腔鳞癌对顺铂敏感性的关系[J].口腔颌面外科杂志,2005,15(2):128-131. 被引量:6
  • 2周晓健,张志愿,张萍,潘红芽,陈万涛,叶冬霞.舌鳞状细胞癌顺铂耐药细胞系细胞周期蛋白D1 RNA干扰的体外研究[J].中华口腔医学杂志,2006,41(11):646-649. 被引量:4
  • 3Pignon JP, Bourhis J, Domenge C,et al. Chemotherapy added to loeoregional treatment for head and neck squamous cell carcinoma: Three meta-analyses of updated individual data. MACH-NC collaborative group . Meta-analysis of chemotherapy on head and neck cancer. Lancet, 2000, 355 (9208) : 949-955.
  • 4Landis SH, Murray T, Bolden S, et al. Cancer statistics, 1999. CA Cancer J Clin ,1999, 49(1) : 8-31.
  • 5Zhang P, Zhang Z, Zhou X, et al. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. BMC Cancer, 2006, 6(2) :224.
  • 6Taylor CG, Sargent JM, Elgie AW, et al. Chemosensitivityting predicts survival in ovarian cancer. Eur J Gynaecol Oncol, 2001, 22(4) :278-282.
  • 7Jiang Q, Feng M G, Mo YY. Systematic validation of predicted microRNAs for cyclin D1[J].BMC Cancer, 2009,18 (9) : 194.
  • 8Murray A W. Recycling the cell cycle: Cyclins revisited[ J ]. Cell,2004,116:221-234.
  • 9Donnellan R, C hetty R. CyclinD1 and Human Neoplasia [ J ]. Mol pathol, 1998,51 : 1-7.
  • 10Morgan D O. Principles of CDK mgulatian[ J]. Nature, 1995,374:131-134.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部